STAT

Opinion: Microhospitals and healthplexes offer a peek at the future of health care

Smaller may trump larger when it comes to better, less expensive health care.

The once insular health care industry now finds itself facing the fallout from decades spent resisting change: an all-sides blitz orchestrated by outsiders intent on doing the changing for it. Besieged by upstarts and titans alike, even the most change-averse organizations are being forced to adapt to this threat. For leaders already laying foundations for innovation within the industry, these disruptions are providing new platforms on which to build the health care delivery models of the future.

Hospitals have long been the exemplar of the old-school model, where bigger is better, evolution is met with suspicion, and more services — regardless of their necessity — mean more lucrative kickbacks from the regulators in charge. As hospitals cling to

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks